Quick answers
- What is Zirabev?
- Zirabev is a brand name of Bevacizumab-bvzr, a prescription medicine. The FDA NDC Directory lists 2 Zirabev products in 2 strengths and forms.
- Who makes Zirabev?
- Pfizer Inc holds the FDA application for Zirabev (BLA761099, approved June 27, 2019).
- Is there a generic or store brand of Zirabev?
- Yes. The FDA NDC Directory lists 8 other products with the same active ingredients, strength and form as a Zirabev product. Ask your pharmacist whether one is right for you.
- Has Zirabev been recalled?
- No recall linked to Zirabev products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Zirabev is
Each Zirabev product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Bevacizumab-bvzr · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| bevacizumab 100 mg/4 mL injection, solution (intravenous) | Zirabev | 4 products, 4 companies | DailyMed |
| bevacizumab 400 mg/16 mL injection, solution (intravenous) | Zirabev | 4 products, 4 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Bevacizumab-bvzr →
FDA approval
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| BLA761099 | Pfizer Inc | June 27, 2019 | 2 |
Companies that list Zirabev
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Zirabev products.
- Pfizer Laboratories Div Pfizer Inc2 products
Recalls
No recall linked to Zirabev products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.